公司资料
Synaptogenix 股价、新闻与催化剂
- 股票代码:
- SNPX
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
24.55 USD (+1.20%)
收盘价
最后更新: 2026年4月20日
—
市值
股价为何变动
Current closing-price context is not available for SNPX.
公司概览
业务概览
Synaptogenix is a biotechnology company focused on neurodegenerative disease and synaptic biology. Its story centers on trying to translate brain-health science into therapies for difficult neurologic conditions.
所在地与行业分类
Synaptogenix is headquartered in the United States and listed on NASDAQ. It sits in small-cap neuroscience biotechnology.
商业模式特征
The company depends on clinical and translational progress, capital efficiency, and the ability to maintain a focused neurologic thesis. Investors usually watch early data and strategic direction.
生物医药行业定位
Synaptogenix occupies a small neuroscience niche within biotech. It remains catalyst-sensitive because the company still needs to prove its platform in a difficult disease area.
未来催化剂
- Synaptogenix is a legacy / closeout story now, with catalysts limited to any strategic update. The market is not treating it like an active growth story.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。